Cargando...
Artesunate enhances the therapeutic response of glioma cells to temozolomide by inhibition of homologous recombination and senescence
Glioblastoma multiforme (GBM), a malignant brain tumor with a dismal prognosis, shows a high level of chemo- and radioresistance and, therefore, attempts to sensitize glioma cells are highly desired. Here, we addressed the question of whether artesunate (ART), a drug currently used in the treatment...
Guardado en:
| Publicado en: | Oncotarget |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Impact Journals LLC
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5341871/ https://ncbi.nlm.nih.gov/pubmed/27626497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11972 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|